Patents by Inventor Kong-Nan Zhao

Kong-Nan Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11103560
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: August 31, 2021
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20210000925
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: August 4, 2020
    Publication date: January 7, 2021
    Inventors: Paul MASCI, Kong-Nan ZHAO, Martin LAVIN, John DE JERSEY, Goce DIMESKI
  • Patent number: 10786553
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: September 29, 2020
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20170304407
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: October 23, 2015
    Publication date: October 26, 2017
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski